News

November 20, 2015 9:15 am
First Irreversible Proteasome Inhibitor for Relapsed Multiple Myeloma Approved in the European Union. Approval Based on Data From Pivotal Phase 3 ASPIRE Trial Which Demonstrated Patients Treated With Kyprolis in Combination Lived Nearly Nine Months...
November 19, 2015 12:00 pm
•FDA Approves Ninlaro, New Oral Medication to Treat Multiple Myeloma - The U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with Revlimid and dexamethasone to treat people with multiple myeloma who have...
November 16, 2015 12:00 pm
FDA Approves New Drug for Myeloma - The U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior treatments. Darzalex is the first...
November 16, 2015 11:45 am
Today the U.S. Food and Drug Administration granted accelerated approval for Darzalex (daratumumab) to treat patients with multiple myeloma who have received at least three prior treatments. Darzalex is the first monoclonal antibody approved for...

Pages